| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Issuance( Retirement)of Debt Net | -35.57 | -40.90 | -15.48 | 3.16 |
| Net Changein Cash | 92.51 | 20.84 | 176.03 | 94.38 |
| Cash Taxes Paid | 125.90 | 122.35 | 63.01 | 72.86 |
| Net Income/ Starting Line | 503.97 | 423.53 | 337.65 | 247.51 |
| Total Cash Dividends Paid | -27.19 | -22.66 | -10.17 | -10.58 |
| Changesin Working Capital | -366.67 | -248.54 | -174.48 | -183.56 |
| Cashfrom Operating Activities | 206.66 | 230.41 | 237.41 | 99.26 |
| Cash Interest Paid | 2.39 | 5.17 | 6.07 | 4.22 |
| Cashfrom Financing Activities | -65.15 | -68.73 | 197.83 | 79.51 |
| Depreciation/ Depletion | 83.39 | 74.27 | 51.85 | 44.78 |
| Other Investing Cash Flow Items Total | 123.91 | 68.00 | -205.58 | -38.06 |
| Capital Expenditures | -172.92 | -208.84 | -53.63 | -46.33 |
| period Type | - | - | - | - |
| Non- Cash Items | -14.02 | -18.85 | 22.38 | -9.47 |
| Financing Cash Flow Items | -2.39 | -5.17 | -6.07 | -4.22 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -49.01 | -140.84 | -259.21 | -84.39 |
| Issuance( Retirement)of Stock Net | - | 0.00 | 229.54 | 91.16 |
| Foreign Exchange Effects | - | 0.00 | 0.00 | 0.00 |
Marksans Pharma Dividend Marksans Pharma Bonus Marksans Pharma News Marksans Pharma AGM Marksans Pharma Rights Marksans Pharma Splits Marksans Pharma Board Meetings Marksans Pharma Key Metrics Marksans Pharma Shareholdings Marksans Pharma Profit Loss Marksans Pharma Balance Sheet Marksans Pharma Q1 Results Marksans Pharma Q2 Results Marksans Pharma Q3 Results Marksans Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks